PROS1 and COVID-19: Previous data shows that, when measured as IgG antibodies against S protein or RBD and NAb, immune response after two doses of SARS‐CoV‐2 vaccine is similar to that observed in convalescent sera from COVID‐19 patients (45, 46, 47, 48).